Hasan, K. M., A. Y. Elmeshhadany, and N. P. Shabila. “Evaluation of Ruxolitinib Versus Best Available Therapy in Treating Primary Myelofibrosis”. Sultan Qaboos University Medical Journal, vol. 22, no. 3, Aug. 2022, pp. 393-9, doi:10.18295/squmj.8.2021.110.